Co-Authors
This is a "connection" page, showing publications co-authored by David Rubin and Noa Cleveland.
Connection Strength
3.788
-
Dose escalation of biologics in biologic-naive patients with Crohn's disease: Outcomes from the ODESSA-CD study. J Manag Care Spec Pharm. 2024 Nov; 30(11):1276-1287.
Score: 0.906
-
The Arrival of Intestinal Ultrasound for Inflammatory Bowel Disease Care in the United States. Gastroenterol Hepatol (N Y). 2023 Mar; 19(3):147-154.
Score: 0.806
-
CANCER PREVENTION IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE. Pract Gastroenterol. 2021 Aug; 45(8):12-28.
Score: 0.723
-
Many Inflammatory Bowel Disease Patients Are Not Immune to Measles or Pertussis. Dig Dis Sci. 2016 10; 61(10):2972-2976.
Score: 0.513
-
Hypertensive Emergency After Initiating Ozanimod: A Case Report. Inflamm Bowel Dis. 2022 08 01; 28(8):e114-e115.
Score: 0.194
-
Ozanimod in the Treatment of Ulcerative Colitis: Initial Real-World Data From a Large Tertiary Center. Clin Gastroenterol Hepatol. 2023 08; 21(9):2407-2409.e2.
Score: 0.189
-
Use of Tofacitinib for the Treatment of Arthritis Associated With Ulcerative Colitis. ACG Case Rep J. 2019 Sep; 6(9):e00226.
Score: 0.159
-
The Role of Biosimilars in Inflammatory Bowel Disease. Gastroenterol Hepatol (N Y). 2016 Dec; 12(12):741-751.
Score: 0.131
-
International Magnetic Resonance Imaging Consensus for use in Luminal Crohn's Disease Trials and Clinical Practice. Clin Gastroenterol Hepatol. 2025 Aug 27.
Score: 0.060
-
Point-of-Care Ultrasound in Gastroenterology and Hepatology. Clin Gastroenterol Hepatol. 2025 Jul; 23(8):1277-1290.
Score: 0.057
-
Ultrasonographic Transmural Healing in Crohn's Disease. Am J Gastroenterol. 2023 06 01; 118(6):961-969.
Score: 0.051